FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

The U.S. Food and Drug Administration has approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).

Leave A Comment

Your email address will not be published. Required fields are marked *